Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Haruyuki Ogura"'
Autor:
Yoshiyuki Miyazawa, Yoshitaka Sekine, Seiji Arai, Toshiyuki Nakamura, Yutaka Takezawa, Nobuaki Shimizu, Yasushige Matsuo, Haruyuki Ogura, Tomoyuki Takei, Kazuhiro Suzuki
Publikováno v:
European Urology Open Science, Vol 29, Iss , Pp 59-67 (2021)
Background: Enzalutamide (ENZ) is used to treat patients with castration-resistant prostate cancer (CRPC). However, the kinetics of serum androgens before and after ENZ treatment are unknown. Objective: To elucidate the kinetics of serum androgens an
Externí odkaz:
https://doaj.org/article/4a029014318d4634806cd08144443f9e
Autor:
Yoshiyuki Miyazawa, Toshiyuki Nakamura, Yutaka Takezawa, Nobuaki Shimizu, Yasushige Matsuo, Haruyuki Ogura, Tomoyuki Takei, Yoshitaka Sekine, Seiji Arai, Kazuhiro Suzuki
Publikováno v:
The Prostate. 83:759-764
Autor:
Tomohiro, Magari, Kayo, Tomomatsu, Namiko, Okugi, Kyoko, Baba, Yosuke, Furuya, Ryo, Oki, Haruyuki, Ogura, Yumiko, Takagi, Kazuto, Ito, Isao, Kurosawa
Publikováno v:
Hinyokika kiyo. Acta urologica Japonica. 68(3)
The continence self-management programme fee (CSPF) for hospitalized patients was revised in 2020 to include those receiving consistent care on an out-patient basis. We extracted candidate patients for CSPF on an out-patient basis (out-patient candid
Autor:
Seiji Arai, Haruyuki Ogura, Yoshitaka Sekine, Tomoyuki Takei, Kazuhiro Suzuki, Nobuaki Shimizu, Yoshiyuki Miyazawa, Yasushige Matsuo, Yutaka Takezawa, Toshiyuki Nakamura
Publikováno v:
European Urology Open Science
European Urology Open Science, Vol 29, Iss, Pp 59-67 (2021)
European Urology Open Science, Vol 29, Iss, Pp 59-67 (2021)
Background Enzalutamide (ENZ) is used to treat patients with castration-resistant prostate cancer (CRPC). However, the kinetics of serum androgens before and after ENZ treatment are unknown. Objective To elucidate the kinetics of serum androgens and
Publikováno v:
Journal of Medical and Biological Engineering. 40:53-61
The heterogeneous distribution of red blood cells (RBCs) in the microcirculatory system is a complicated phenomenon because many factors influence how they are partitioned at microvascular bifurcations. In this study, we investigated the RBC partitio
Autor:
Yoshiyuki Miyazawa, Toshiyuki Nakamura, Yutaka Takezawa, Nobuaki Shimizu, Yasushige Matsuo, Haruyuki Ogura, Tomoyuki Takei, Seiji Arai, Yoshitaka Sekine, Kazuhiro Suzuki
Publikováno v:
Journal of Clinical Oncology. 40:79-79
79 Background: Enzalutamide (ENZ) is used to treat patients with castration-resistant prostate cancer (CRPC). Quality of life (QOL) during ENZ treatment for CRPC patients is very important, but the markers that predict QOL are unknown. We investigate
Autor:
Yasuhiro Shibata, Yoshitaka Sekine, Hidekazu Koike, Haruyuki Ogura, Yutaka Takezawa, Hiroshi Matsui, Kazuhiro Suzuki, Toshiyuki Nakamura, Takeshi Miyao, Nobuaki Shimizu, Yoshiyuki Miyazawa, Yasushige Matsuo, Seiji Arai, Tomoyuki Takei, Daisuke Oka
Publikováno v:
Journal of Clinical Oncology. 38:146-146
146 Background: Enzalutamide (ENZ) is commonly used to treat patients with castration resistant prostate cancer (CRPC). However, the kinetics of serum androgen levels before and after ENZ treatment are unknown. We elucidated the kinetics of serum and
Autor:
Osamu Maruyama, Ryo Kosaka, Masahiro Nishida, Yoshihiro Yamamoto, Daisuke Sakota, Haruyuki Ogura, Katsuyuki Kuwana, Toru Hyakutake
Publikováno v:
The Proceedings of the Bioengineering Conference Annual Meeting of BED/JSME. :1E35
Autor:
Katsuyuki Kuwana, Ryo Kosaka, Yoshihiro Yamamoto, Toru Hyakutake, Takashi Yamane, Daisuke Sakota, Masahiro Nishida, Osamu Maruyama, Haruyuki Ogura
Publikováno v:
The Proceedings of the Bioengineering Conference Annual Meeting of BED/JSME. :1E31
Autor:
Haruyuki Ogura, Osamu Maruyama, Katsuyuki Kuwana, Toru Hyakutake, Daisuke Sakota, Ryo Kosaka, Masahiro Nishida, Yoshihiro Yamamoto
Publikováno v:
The Proceedings of the Bioengineering Conference Annual Meeting of BED/JSME. :2D32